List of insiders holdings for CERO THERAPEUTICS HOLDINGS INC.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| 1 | SLOAN STUART M 10% Owner | 2024-11-20 16:06:55 | 21,067,956 0 | 21,067,956 | Form 13G |
| 2 | Ehrlich Christopher B Chairman and CEO | 2026-01-09 16:30:15 | 4,530,997 0 | 4,530,997 | Form 4 |
| 3 | Francois Eric Director | 2026-04-21 19:46:43 | 1,823,278 0 | 1,823,278 | Form 4 |
| 4 | ATWOOD BRIAN G Director | 2026-01-09 16:30:17 | 1,612,099 0 | 1,612,099 | Form 4 |
| 5 | Pierce Kristen Chief Development Officer | 2026-01-09 16:30:21 | 1,612,099 0 | 1,612,099 | Form 4 |
| 6 | KUCHARCHUK ANDREW ALBERT Chief Financial Officer | 2026-01-09 16:30:12 | 1,162,099 0 | 1,162,099 | Form 4 |
| 7 | PHOENIX BIOTECH SPONSOR LLC 10% Owner | 2024-02-20 17:18:13 | 1,015,000 0 | 1,015,000 | Form 13D |
| 8 | Corey Daniel Chief Technical Officer | 2024-03-27 21:27:21 | 856,671 0 | 856,671 | Form 4 |
| 9 | Rolfe Lindsey Director | 2026-01-09 16:30:24 | 690,900 0 | 690,900 | Form 4 |
| 10 | LAPORTE KATHLEEN Director | 2026-01-09 16:30:22 | 690,900 0 | 690,900 | Form 4 |
| 11 | Patel Shami Director | 2026-01-09 16:30:19 | 690,900 0 | 690,900 | Form 4 |
| 12 | Byrnes Michael Director | 2026-01-09 16:30:13 | 690,900 0 | 690,900 | Form 4 |
| 13 | Rapaport Robyn Director | 2024-03-27 21:28:50 | 112,500 0 | 112,500 | Form 4 |
| 14 | Carter Charles Ross Chief Financial Officer | 2024-07-01 16:01:02 | 100,000 0 | 100,000 | Form 4 |
| 15 | Fisher Douglas Carl President | 2024-02-16 19:39:11 | 91,650 0 | 91,650 | Form 4 |
| 16 | Geffken Daniel E. Chief Financial Officer | 2024-02-16 19:39:38 | 20,004 0 | 20,004 | Form 4 |
| 17 | YK Bioventures Opportunities GP I LLC YK Bioventures Opportunities Fund I L.P. Kossar Mitchell William Yeung Gary Kahing 10% Owner | 2024-12-17 19:26:26 | 17,002 0 | 17,002 | Form 13G |
| 18 | Loewy Caroline M Director | 2024-02-16 19:41:23 | 11,656 0 | 11,656 | Form 4 |
| 19 | Kosacz Barbara Director | 2024-02-16 19:40:38 | 11,656 0 | 11,656 | Form 4 |